Henry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
Follow HSIC
Henry Schein, Inc. (HSIC) EV/FCF
As of 16 October 2026, Henry Schein, Inc. (HSIC) trades at a EV/FCF of 21.2×. Over the past ten years it has ranged from 10.2× (April 2020) to 35.2× (February 2024); the current reading is higher than 72% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 19.8× | 31.21% |
| FY2024 | 15.1× | (54.91%) |
| FY2023 | 33.4× | 43.66% |
| FY2022 | 23.2× | 26.80% |
| FY2021 | 18.3× | 3.58% |
| FY2020 | 17.7× | (2.51%) |
| FY2019 | 18.2× | 7.76% |
| FY2018 | 16.8× | (14.68%) |
| FY2017 | 19.7× | 6.57% |
| FY2016 | 18.5× | (5.75%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 20.7× | (14.03%) |
| Mar 2026 | 24.0× | 21.68% |
| Dec 2025 | 19.8× | (20.59%) |
| Sep 2025 | 24.9× | (13.34%) |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| ACH Accendra Health, Inc. compare | −11.0× |
| FOCL FocalTherics compare | −8.7× |
| COSM Cosmos Health Inc. compare | −2.3× |
| AHG Akso Health Group Sponsored ADR compare | −0.2× |
| HKPD Cellyan Biotechnology Co., Ltd compare | 5.0× |
| CAH Cardinal Health, Inc. compare | 14.0× |
| COR Cencora, Inc. compare | 18.2× |
| MCK McKesson Corporation compare | 21.0× |
| HSIC Henry Schein, Inc. | 21.2× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on HSIC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement